P223-1205 Screening compound: 5-(2-METHOXYETHYL)-2-{1-[(PYRIDIN-3-YL)METHYL]PIPERIDIN-3-YL}-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPIN-4-ONE

P223-1205 Screening compound: 5-(2-METHOXYETHYL)-2-{1-[(PYRIDIN-3-YL)METHYL]PIPERIDIN-3-YL}-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPIN-4-ONE
P223-1205 Screening compound: 5-(2-METHOXYETHYL)-2-{1-[(PYRIDIN-3-YL)METHYL]PIPERIDIN-3-YL}-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPIN-4-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound P223-1205
5-(2-METHOXYETHYL)-2-{1-[(PYRIDIN-3-YL)METHYL]PIPERIDIN-3-YL}-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPIN-4-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P223-1205

Molecular Formula

C21H29N5O2 (C21 H29 N5 O2)

Compound Name

5-(2-METHOXYETHYL)-2-{1-[(PYRIDIN-3-YL)METHYL]PIPERIDIN-3-YL}-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPIN-4-ONE

IUPAC name

5-(2-methoxyethyl)-2-{1-[(pyridin-3-yl)methyl]piperidin-3-yl}-4H5H6H7H8H-pyrazolo[15-a][14]diazepin-4-one

SMILES

COCCN(CCCn1nc(C2CN(Cc3cnccc3)CCC2)cc11)C1=O

InChI

InChI=1S/C21H29N5O2/c1-28-12-11-25-9-4-10-26-20(21(25)27)13-19(23-26)18-6-3-8-24(16-18)15-17-5-2-7-22-14-17/h2,5,7,13-14,18H,3-4,6,8-12,15-16H2,1H3/t18-/m0/s1

InChI Key

DIBXFOMAQKYAJB-SFHVURJKSA-N

MDL Number (MFCD)

MFCD31952691

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

383.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

0.698

Distribution Coefficient, logD

-0.524

Water Solubility, LogSw

-0.78

Polar Surface Area

51.886

Acid Dissociation Constant (pKa)

26.38

Base Dissociation Constant (pKb)

8.59

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

57.10

P223-1205 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Nervous system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P223-1205 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P223-1205?
Check Price and Availability of P223-1205, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P223-1205 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P223-1205
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P223-1205
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P223-1205 available by request